Sandoz Sees Room For Improvements To US Market
Carol Lynch, President Of Sandoz US, Identifies Key Reforms Necessary
Overcoming residual negative perceptions around generics, reforming Medicaid and Medicare policies that unfairly penalize generics and ensuring that “skinny label” generics can continue to be marketed are among the key priorities for Sandoz in the US, Carol Lynch, president of Sandoz Inc. and head of North America, tells Generics Bulletin in an exclusive interview.
